Director at REGENXBIO (RGNX) receives RSU and option grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
REGENXBIO Inc. reported that director Alexandra Glucksmann received new equity awards. She was granted 9,807 shares of Common Stock in the form of a time-based restricted stock unit award, which will vest 100% on May 29, 2027 if she continues service with the company.
She was also granted stock options covering 46,600 shares of Common Stock at an exercise price of $7.01 per share. These options will vest on May 29, 2027 and expire on May 29, 2036. Following the grants, she directly holds 28,861 Common Stock shares and 46,600 options. These are compensation awards rather than open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Glucksmann Alexandra
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 46,600 | $0.00 | -- |
| Grant/Award | Common Stock | 9,807 | $0.00 | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 46,600 shares (Direct, null);
Common Stock — 28,861 shares (Direct, null)
Footnotes (1)
- Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer. The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer.
Key Figures
RSU shares granted: 9,807 shares
Options granted: 46,600 options
Option exercise price: $7.01 per share
+4 more
7 metrics
RSU shares granted
9,807 shares
Time-based RSU award vesting May 29, 2027
Options granted
46,600 options
Stock Options (Right to Buy) granted May 29, 2026
Option exercise price
$7.01 per share
Conversion/exercise price for 46,600 options
Option vesting date
May 29, 2027
Vesting date for stock options and RSU award
Option expiration
May 29, 2036
Expiration date for 46,600 stock options
Shares held after grant
28,861 shares
Total Common Stock directly held after RSU grant
Options held after grant
46,600 options
Total stock options directly held after grant
Key Terms
restricted stock unit award (RSU), Stock Options (Right to Buy), exercise price, vesting, +1 more
5 terms
restricted stock unit award (RSU) financial
"Represents shares of common stock underlying a time-based restricted stock unit award (RSU)."
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 7.0100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"100% of the shares subject to this RSU will vest on May 29, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-05-29T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transactions did REGENXBIO (RGNX) report for Alexandra Glucksmann?
REGENXBIO reported that director Alexandra Glucksmann received equity compensation grants, not open-market trades. She was awarded 9,807 RSU shares and stock options on 46,600 shares, all granted on May 29, 2026, subject to future vesting conditions.
What are the terms of Alexandra Glucksmann’s stock options at REGENXBIO (RGNX)?
She was granted stock options for 46,600 REGENXBIO common shares at an exercise price of $7.01 per share. These options vest on May 29, 2027 and have an expiration date of May 29, 2036, giving a long exercise window.
Are Alexandra Glucksmann’s REGENXBIO (RGNX) equity awards immediately vested?
No, both awards are subject to future vesting. The 9,807 RSU shares and the 46,600 stock options each vest on May 29, 2027, conditioned on Ms. Glucksmann’s continuous service to REGENXBIO through that date.